En direct

Sep Jul 2015 Molecular & cellular oncology

ERBB2 oncogenicity: ERBIN helps to perform the job.

Auteurs

Mei L, Borg JP

Résumé

ERBB2 (v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2) is an oncogenic tyrosine kinase receptor that is overexpressed in breast cancer. Antibodies and inhibitors targeting ERBB2 are currently available, although therapeutic failures remain frequent. We discuss here recent data showing that the scaffold protein ERBB2IP (ERBB2 interacting protein, best known as ERBIN) regulates ERBB2 stability and may represent a future therapeutic target.

Lire l‘article